Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Favourite items of Peter Mansfield

Page 1 of 1 pages

Smith R.
Curbing the Influence of the Drug Industry: A British View.
PLoS Med 2005 Aug 22:(9):e241

Adair RF, Holmgren LR.
Do drug samples influence resident prescribing behavior? A randomized trial.
Am J Med 2005 Aug118:(8):881-4

Zipkin DA, Steinman MA.
Interactions Between Pharmaceutical Representatives and Doctors in Training: A thematic review.
J Gen Intern Med 2005 Jun 1320:(8):777-86

Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO.
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
Med J Aust 2005 Jun 6182:(11):557-60

Brodkey AC.
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
Acad Psychiatry 2005 Sum29:(2):222-9

Freudenberg N.
Public health advocacy to change corporate practices: implications for health education practice and research.
Health Educ Behav 2005 Jun32:(3):298-319

Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P.
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
JAMA 2005 Apr 27293:(16):1995-2002

Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K.
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Intern Med J 2005 Apr35:(4):206-10

Mansfield PR, Mintzes B, Richards D, Toop L.
Direct to consumer advertising.
BMJ 2005 Jan 1330:(7481):5-6

Mansfield P.
Accepting what we can learn from advertising's mirror of desire.
BMJ 2004 Dec 18329:(7480):1487-8

Scott T, Stanford N, Thompson DR.
Killing me softly: myth in pharmaceutical advertising.
BMJ 2004 Dec 18329:(7480):1484-7

Douglas KM, Sutton RM.
Right about others, wrong about ourselves? Actual and perceived self-other differences in resistance to persuasion
Br J Soc Psychol 2004 Dec43:(Pt 4):585-603

Mansfield PR, Henry D.
Misleading drug promotion--no sign of improvements.
Pharmacoepidemiol Drug Saf 2004 Nov13:(11):797-9

Sweet M.
Doctors and drug companies are locked in 'vicious circle'.
BMJ 2004 Oct 30329:(7473):998

Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May79:(5):432-7

Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24363:(9418):1341-5

Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19180:(8):411-4

Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19180:(8):409-10

Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10328:(7444):879-83

Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb30:(1):8-24

Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-JunSuppl Web Exclusives:W4-234-45

Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb73:(1):10-6

Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15179:(11-12):644-5

Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12290:(18):2404-5

Dana J, Loewenstein G.
A social science perspective on gifts to physicians from industry.
JAMA 2003 Jul 9290:(2):252-5

Mansfield PR.
Bribes for doctors: a gift for bioethicists?
Am J Bioeth 2003 Summer3:(3):47-8

Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29168:(9):1133-7

Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr18:(4):294-7

Prosser H, Almond S, Walley T.
Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Fam Pract 2003 Feb20:(1):61-8

Villanueva P, Peiro S, Librero J, Pereiro I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 Jan 4361:(9351):27-32

Katz D, Caplan AL, Merz JF.
All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Am J Bioeth 20033:(3):39-46

Braithwaite J.
Restorative Justice and Responsive Regulation
Oxford: Oxford University Press 2002

Brotons C, Moral I, Ribera A, Cascant P, Iglesias M, Permanyer-Miralda G, Ferreira Gonzalez I, Soler-Soler J.
[Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention.]
Rev Esp Cardiol 2002 Oct55:(10):1042-51

Loke TW, Koh FC, Ward JE.
Pharmaceutical advertisement claims in Australian medical publications.
Med J Aust 2002 Sep 16177:(6):291-3

Sagarin BJ, Cialdini RB, Rice WE, Serna SB.
Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion.
J Pers Soc Psychol 2002 Sep83:(3):526-41

Hall KH.
Reviewing intuitive decision-making and uncertainty: the implications for medical education.
Med Educ 2002 Mar36:(3):216-24

Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002324:278-279

Choudhry NK, Stelfox HT, Detsky AS
Relationships between authors of clinical practice guidelines and the pharmaceutical industry
JAMA 2002287:612-617

Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec76:(12):1271-1277

Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30165:(9):1226-37

McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31286:(16):1994-9

Jones MI, Greenfield SM, Bradley CP.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2001323:378-384

Woloshin S, Schwartz LM, Tremmel J, Welch HG
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
Lancet 2001358:1141-1146

Ainslie G.
Breakdown of Will
Cambridge: Cambridge University Press 2001

Norman GR.
The epistemology of clinical reasoning: perspectives from philosophy, psychology, and neuroscience.
Acad Med 2000 Oct75:(10):

Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB.
Coverage by the news media of the benefits and risks of medications.
N Engl J Med 2000 Jun 1342:(22):1645-50

Cialdini RB.
Influence: Science and Practice 4th Edn
New York: Allyn & Bacon 2000,1144,0321011473,00.html

Braithwaite J, Drahos P.
Global business regulation.
Cambridge: Cambridge University Press 2000

Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin 2000

Elstein AS.
Heuristics and biases: selected errors in clinical reasoning.
Acad Med 1999 Jul74:(7):791-4

Kamat VR, Nichter M.
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India.
Soc Sci Med 1998 Sep47:(6):779-94

Roughead EE, Harvey KJ, Gilbert AL.
Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.
Aust N Z J Med 1998 Jun28:(3):306-10

Stelfox HT, Chua G, O'Rourke K, Detsky AS.
Conflict of interest in the debate over calcium-channel antagonists.
N Engl J Med 1998 Jan 8338:(2):101-6

Roughead EE, Gilbert AL, Harvey KJ.
Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?
Int J Health Serv 199828:(2):269-79

Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May43:941-5

Stryer D, Bero LA.
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
J Gen Intern Med 1996 Oct11:(10):575-83

Wolfe S.
Drug advertisements that go straight to the hippocampus.
Lancet 1996 Sep 7348:(9028):632

Estes R.
Tyrany of the bottom line: Why corporations make good people do bad things.
San Francisco: Berrett-Koehler 1996

Barlow J, Møller C.
A complaint is a gift. Using customer feedback as a strategic tool.
San Francisco: Berrett-Koehler 1996

Ziegler MG, Lew P, Singer BC.
The accuracy of drug information from pharmaceutical sales representatives.
JAMA 1995 Apr 26273:(16):1296-8

Lexchin J.
Deception by design: Pharmaceutical promotion in the Third World
Penang: Consumers International 1995

Bardelay D, Bécel B.
Visits from medical representatives: fine principles, poor practice
Prescrire International 19954:(18):120-122

Ogilvy D.
Ogilvy on advertising.
London: Prion 1995

Branthwaite A, Downing T.
Marketing to doctors - the human factor.
Scrip Magazine 199532-5

Shaughnessy AF, Slawson DC, Bennett JH.
Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion.
J Gen Intern Med 1994 Oct9:(10):563-8

Scott DK, Ferner RE.
'The strategy of desire' and rational prescribing.
Br J Clin Pharmacol 1994 Mar37:(3):217-9

Ayres I, Braithwaite J.
Responsive regulation: Transcending the deregulation debate.
Oxford: Oxford University Press 1992

Goleman D.
Vital lies, simple truths: The psychology of self-deception.
London: Bloomsbury 1985

Avorn J, Chen M, Hartley R.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med 1982 Jul73:(1):4-8

Kahneman D, Slovic P, Tversky A.
Judgment under uncertainty: heuristics and biases.
New York: Cambridge University Press 1982

Fischer DH.
Historian's Fallacies: Toward a logic of historical thought.
New York: Harper Torchbooks 1970

Hamblin CL.
London: Methuen 1970

Talalay P, Editor.
Drugs in Our Society.
Baltimore: John Hopkins Press 1964

Hopkins CC.
My Life in Advertising.
Chicago: 1996 reprint by NTC Business Books 1927

Hopkins CC.
Scientific advertising.
Chicago: 1996 reprint by NTC Business Books 1923

Locke J.
An essay concerning human understanding

Date uncertain 350 350 BCE

Page 1 of 1 pages


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.